HALO
Halozyme Therapeutics Inc
Price:  
60.43 
USD
Volume:  
1,857,612.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

HALO Fair Value

10.14 %
Upside

As of 2024-10-04, the Fair Value of Halozyme Therapeutics Inc (HALO) is 66.56 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 60.43 USD, the upside of Halozyme Therapeutics Inc is 10.14%.

60.43 USD
Stock Price
66.56 USD
Fair Price
FAIR VALUE CALCULATION

HALO Fair Value

Peter Lynch's formula is:

HALO Fair Value
= Earnings Growth Rate x TTM EPS
HALO Fair Value
= 25.00 x 2.66
HALO Fair Value
= 66.56

The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings
2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31 5Y Avg
Net income -72.20 129.10 402.70 202.10 281.59 188.66
YoY growth 10.09% 278.81% 211.93% -49.81% 39.33% 98.07%

HALO Fair Value - Key Data

Market Cap (mil) 7,655.27
P/E 22.70x
Forward P/E 23.48x
EPS 2.66
Avg earnings growth rate 98.07%
TTM earnings 337.26